Stock A372910 HANCOM LIFECARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Hancom Lifecare Inc.

Equities

A372910

KR7372910000

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
5,560 KRW -0.71% Intraday chart for Hancom Lifecare Inc. -8.25% +22.60%
2023 Hancom Lifecare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2021 Hancom Lifecare Inc. has completed an IPO in the amount of KRW 113.741798 billion. CI

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company shows low valuation levels, with an enterprise value at 1180.4 times its sales.
  • The company appears to be poorly valued given its net asset value.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Sales forecast by analysts have been recently revised upwards.
  • For several months, analysts have been revising their EPS estimates roughly upwards.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
HANCOM LIFECARE INC. Stock Hancom Lifecare Inc.
+22.60% 115M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.27% 182B
C+
MEDTRONIC PLC Stock Medtronic plc
+4.19% 114B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.21% 68.38B
A
DEXCOM, INC. Stock DexCom, Inc.
+5.96% 52.46B
B-
CENCORA, INC. Stock Cencora, Inc.
+8.09% 44.25B
B-
HOYA CORPORATION Stock Hoya Corporation
+7.52% 43.55B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+24.50% 32.69B
B
TERUMO CORPORATION Stock Terumo Corporation
+17.85% 26.73B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-0.69% 25.79B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
-
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. A372910 Stock
  4. Ratings Hancom Lifecare Inc.